• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测人类免疫缺陷病毒(HIV)感染者亚临床冠状动脉疾病的多基因风险评分:瑞士HIV队列研究

Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study.

作者信息

Schoepf Isabella C, Thorball Christian W, Kovari Helen, Ledergerber Bruno, Buechel Ronny R, Calmy Alexandra, Weber Rainer, Kaufmann Philipp A, Nkoulou René, Schwenke Johannes M, Braun Dominique L, Fellay Jacques, Tarr Philip E

机构信息

Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Hepatology, Department for Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

出版信息

Clin Infect Dis. 2023 Jan 6;76(1):48-56. doi: 10.1093/cid/ciac758.

DOI:10.1093/cid/ciac758
PMID:36097729
Abstract

BACKGROUND

In people with human immunodeficiency virus (HIV) (PWH), individual polygenic risk scores (PRSs) are associated with coronary artery disease (CAD) events. Whether PRSs are associated with subclinical CAD is unknown.

METHODS

In Swiss HIV Cohort Study participants of European descent, we defined subclinical CAD as presence of soft, mixed, or high-risk plaque (SMHRP) on coronary computed tomography (CT) angiography, or as participants in the top tertile of the study population's coronary artery calcium (CAC) score, using noncontrast CT. We obtained univariable and multivariable odds ratios (ORs) for subclinical CAD endpoints based on nongenetic risk factors, and validated genome-wide PRSs built from single nucleotide polymorphisms associated with CAD, carotid intima-media thickness (IMT), or longevity in the general population.

RESULTS

We included 345 genotyped participants (median age, 53 years; 89% male; 96% suppressed HIV RNA); 172 and 127 participants had SMHRP and CAC, respectively. CAD-associated PRS and IMT-associated PRS were associated with SMHRP and CAC (all P < .01), but longevity PRS was not. Participants with unfavorable CAD-PRS (top quintile) had an adjusted SMHRP OR = 2.58 (95% confidence interval [CI], 1.18-5.67), and a CAC OR = 3.95 (95% CI, 1.45-10.77) vs. bottom quintile. Unfavorable nongenetic risk (top vs. bottom quintile) was associated with adjusted SMHRP OR = 24.01 (95% CI, 9.75-59.11), and a CAC-OR = 65.07 (95% CI, 18.48-229.15). Area under the receiver operating characteristic curve increased when we added CAD-PRS to nongenetic risk factors (SMHRP: 0.75 and 0.78, respectively; CAC: 0.80 and 0.83, respectively).

CONCLUSIONS

In Swiss PWH, subclinical CAD is independently associated with an individual CAD-associated PRS. Combining nongenetic and genetic cardiovascular risk factors provided the most powerful subclinical CAD prediction.

摘要

背景

在人类免疫缺陷病毒(HIV)感染者(PWH)中,个体多基因风险评分(PRS)与冠状动脉疾病(CAD)事件相关。PRS是否与亚临床CAD相关尚不清楚。

方法

在瑞士HIV队列研究中具有欧洲血统的参与者中,我们将亚临床CAD定义为冠状动脉计算机断层扫描(CT)血管造影显示存在软斑块、混合斑块或高危斑块(SMHRP),或使用非增强CT检查时处于研究人群冠状动脉钙化(CAC)评分最高三分位数的参与者。我们基于非遗传风险因素获得了亚临床CAD终点的单变量和多变量比值比(OR),并验证了由与CAD、颈动脉内膜中层厚度(IMT)或一般人群寿命相关的单核苷酸多态性构建的全基因组PRS。

结果

我们纳入了345名基因分型参与者(中位年龄53岁;89%为男性;96%的HIV RNA得到抑制);分别有172名和127名参与者有SMHRP和CAC。CAD相关的PRS和IMT相关的PRS与SMHRP和CAC相关(所有P <.01),但寿命相关的PRS则不然。CAD-PRS不利(最高五分位数)的参与者与最低五分位数相比,调整后的SMHRP OR = 2.58(95%置信区间[CI],1.18 - 5.67),CAC OR = 3.95(95% CI,1.45 - 10.77)。非遗传风险不利(最高与最低五分位数)与调整后的SMHRP OR = 24.01(95% CI,9.75 - 59.11)和CAC-OR = 65.07(95% CI,18.48 - 229.15)相关。当我们将CAD-PRS添加到非遗传风险因素中时,受试者工作特征曲线下面积增加(SMHRP:分别为0.75和0.78;CAC:分别为0.80和0.83)。

结论

在瑞士的PWH中,亚临床CAD与个体CAD相关的PRS独立相关。结合非遗传和遗传心血管风险因素可提供最强有力的亚临床CAD预测。

相似文献

1
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study.用于预测人类免疫缺陷病毒(HIV)感染者亚临床冠状动脉疾病的多基因风险评分:瑞士HIV队列研究
Clin Infect Dis. 2023 Jan 6;76(1):48-56. doi: 10.1093/cid/ciac758.
2
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.与冠状动脉疾病和长寿相关的多基因风险评分在预测人类免疫缺陷病毒感染者中的冠状动脉疾病事件中的应用:瑞士艾滋病毒队列研究。
Clin Infect Dis. 2021 Nov 2;73(9):1597-1604. doi: 10.1093/cid/ciab521.
3
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study.抗逆转录病毒药物与瑞士人类免疫缺陷病毒队列研究中的亚临床冠状动脉疾病相关。
Clin Infect Dis. 2020 Feb 14;70(5):884-889. doi: 10.1093/cid/ciz283.
4
Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIV.瑞士艾滋病毒感染者的端粒长度、传统风险因素、与人类免疫缺陷病毒(HIV)相关的因素及冠心病事件
Clin Infect Dis. 2021 Oct 5;73(7):e2070-e2076. doi: 10.1093/cid/ciaa1034.
5
Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.多基因风险评分与 HIV 感染者的临床前期心血管疾病:来自 REPRIEVE 试验的新认识。
J Am Heart Assoc. 2024 Apr 2;13(7):e033413. doi: 10.1161/JAHA.123.033413. Epub 2024 Mar 27.
6
Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons.瑞士 HIV 阳性和 HIV 阴性人群中的亚临床冠状动脉疾病。
Eur Heart J. 2018 Jun 14;39(23):2147-2154. doi: 10.1093/eurheartj/ehy163.
7
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study.白细胞计数与人类免疫缺陷病毒感染者的冠状动脉疾病事件:一项纵向研究。
Clin Infect Dis. 2023 Jun 8;76(11):1969-1979. doi: 10.1093/cid/ciad033.
8
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.在 REPRIEVE 队列中,HIV 感染者的冠状动脉旁脂肪组织密度、炎症与亚临床冠状动脉疾病。
Clin Infect Dis. 2023 Dec 15;77(12):1676-1686. doi: 10.1093/cid/ciad419.
9
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.与 HIV 感染者骨质疏松症相关的多基因风险评分:瑞士 HIV 队列研究。
J Infect Dis. 2023 Sep 15;228(6):742-750. doi: 10.1093/infdis/jiad179.
10
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.遗传背景、传统危险因素和 HIV 相关因素对 HIV 阳性人群冠心病事件的影响。
Clin Infect Dis. 2013 Jul;57(1):112-21. doi: 10.1093/cid/cit196. Epub 2013 Mar 26.

引用本文的文献

1
Types of Myocardial Infarction in People With HIV in Switzerland.瑞士HIV感染者的心肌梗死类型
Open Forum Infect Dis. 2025 Jun 19;12(7):ofaf357. doi: 10.1093/ofid/ofaf357. eCollection 2025 Jul.
2
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus.感染人类免疫缺陷病毒个体的缺血性心脏病中的免疫失调
Heart Fail Clin. 2025 Apr;21(2):227-239. doi: 10.1016/j.hfc.2024.12.005. Epub 2025 Jan 30.
3
Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.
多基因风险评分与 HIV 感染者的临床前期心血管疾病:来自 REPRIEVE 试验的新认识。
J Am Heart Assoc. 2024 Apr 2;13(7):e033413. doi: 10.1161/JAHA.123.033413. Epub 2024 Mar 27.
4
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.与 HIV 感染者骨质疏松症相关的多基因风险评分:瑞士 HIV 队列研究。
J Infect Dis. 2023 Sep 15;228(6):742-750. doi: 10.1093/infdis/jiad179.
5
Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.多基因风险评分指向 HIV 感染者 2 型心肌梗死的潜在遗传机制。
Int J Cardiol. 2023 Jul 15;383:15-23. doi: 10.1016/j.ijcard.2023.04.058. Epub 2023 May 4.